The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 08, 2016

Filed:

Jan. 21, 2014
Applicant:

Helix Biomedix, Inc., Bothell, WA (US);

Inventors:

Lijuan Zhang, Kenmore, WA (US);

Robin Carmichael, Redmond, WA (US);

Assignee:

HELIX BIOMEDIX INC., Bothell, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/07 (2006.01); A61K 38/08 (2006.01); A61K 8/64 (2006.01); A61Q 19/00 (2006.01); A61Q 19/08 (2006.01); C07K 7/06 (2006.01); C07K 5/113 (2006.01); C07K 5/103 (2006.01); C07K 14/435 (2006.01);
U.S. Cl.
CPC ...
C07K 7/06 (2013.01); A61K 8/64 (2013.01); A61Q 19/00 (2013.01); A61Q 19/08 (2013.01); C07K 5/1013 (2013.01); C07K 5/1021 (2013.01); C07K 14/43563 (2013.01); A61K 38/00 (2013.01); A61K 2800/74 (2013.01);
Abstract

Peptides having four to six amino acid residues are disclosed that possess biological activity. These peptides constitute short fragments of the peptide HB-107 (MPKEKVFLKIEKMGRNIRN) (SEQ ID NO: 10), which itself is a fragment of the antimicrobial protein cecropin B, and exhibit cell stimulatory and migratory properties. The inventive peptides comprise four to six contiguous amino acid residues located between position 11 and 16 of HB107 (MPKEKVFLKIEKMGRNIRN) (SEQ ID NO: 10), namely EKMGRN (SEQ ID NO: 1). The disclosed peptides comprise a useful agent for the medical treatment of injury to the skin, such as from diabetic ulcers. The peptides also are effective in preventing and reversing skin surface damage resulting from various environmental insults. Importantly, the therapeutic effects of the peptides manifest at concentrations equal to or greater than those of peptide HB-107 (SEQ ID NO: 10), and thus represent a less expensive, more versatile means for developing effective therapies. Methods for the production and use of these peptides are also disclosed.


Find Patent Forward Citations

Loading…